Association of neovascular age-related macular degeneration with specific gene expression patterns in peripheral white blood cells.

PURPOSE Inflammation probably plays a major role in the pathogenesis of age-related macular degeneration (AMD). The authors evaluated whether AMD is associated with gene expression patterns in white blood cells (WBCs) and whether such a pattern may serve as a biomarker for the disease. METHODS Microarray analysis of gene expression in peripheral WBCs was performed on patients with neovascular AMD (NVAMD; n = 16) and controls (n = 16). Results were validated using quantitative real-time RT-PCR (QPCR) on another set of patients (n = 14) and controls (n = 16), respectively. QPCR findings were evaluated using receiver operator characteristic (ROC) curves and correlated with genotyping for the major risk single nucleotide polymorphisms (SNPs) for AMD in the genes for complement factor H and LOC387715. RESULTS NVAMD-associated expression was identified for eight sequences (false discovery rate [FDR] = 0%) and 167 sequences (FDR = 10%), respectively. There was an enrichment of genes involved in antigen presentation among the AMD-associated genes (P = 0.0029). QPCR confirmed increased expression (1.6- to 4.3-fold) of four genes (HSPA8, IGHG1, ANXA5, VKORC1) in association with NVAMD (P = 0.02-0.0002). Area under the curve for these genes according to ROC analysis ranged from 0.776 to 0.815. Gene expression was not associated with genotyping for risk SNPs or WBC counts. CONCLUSIONS NVAMD is associated with altered gene expression in peripheral WBCs that is not underlined by the major risk SNPs for the disease. Such altered expression may potentially serve as a biomarker for the disease. These data support the involvement of systemic immune response in the pathogenesis of AMD.

[1]  I. Chowers,et al.  Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel , 2008, Molecular vision.

[2]  I. Chowers,et al.  Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel , 2008, Molecular vision.

[3]  G. Parmigiani,et al.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.

[4]  Martin Oppermann,et al.  Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.

[5]  I. Chowers,et al.  Lack of benefit of early awareness to age-related macular degeneration , 2008, Eye.

[6]  P. Mitchell,et al.  The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. , 2008, Ophthalmology.

[7]  I. Simon,et al.  Molecular characteristics of liver metastases from uveal melanoma. , 2007, Investigative ophthalmology & visual science.

[8]  P. Debré,et al.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.

[9]  Johanna M Seddon,et al.  Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.

[10]  F. Ferris,et al.  Age-related macular degeneration and the immune response: implications for therapy. , 2007, American journal of ophthalmology.

[11]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[12]  J. Kowalak,et al.  Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[13]  P. Mitchell,et al.  Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study. , 2007, Investigative ophthalmology & visual science.

[14]  John D Lambris,et al.  Complement and coagulation: strangers or partners in crime? , 2007, Trends in immunology.

[15]  R. Apte,et al.  Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.

[16]  J. Gregg,et al.  Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. , 2006, Genomics.

[17]  Yibo Wang,et al.  VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection) , 2006, Circulation.

[18]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[19]  R. Scott,et al.  Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia , 2006, Schizophrenia Research.

[20]  J. Frostegård,et al.  Annexin A5 in cardiovascular disease and systemic lupus erythematosus. , 2005, Immunobiology.

[21]  R V Jensen,et al.  Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Santa Jeremy Ono,et al.  Circulating anti‐retinal antibodies as immune markers in age‐related macular degeneration , 2005, Immunology.

[23]  B. Rosner,et al.  Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.

[24]  Yibo Wang,et al.  Vitamin K Epoxide Reductase: A Protein Involved in Angiogenesis , 2005, Molecular Cancer Research.

[25]  C. Osmond,et al.  Association of HLA class I and class II polymorphisms with age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.

[26]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[27]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[28]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[29]  E. Chew,et al.  The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  George Stephanopoulos,et al.  Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells , 2004, Journal of Neuroimmunology.

[31]  N. Rifai,et al.  Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.

[32]  M. Miyagi,et al.  Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration* , 2003, Journal of Biological Chemistry.

[33]  Eiji Sakurai,et al.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.

[34]  A. Hackam,et al.  Identification of novel genes preferentially expressed in the retina using a custom human retina cDNA microarray. , 2003, Investigative ophthalmology & visual science.

[35]  K. Csaky,et al.  Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[36]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[37]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[38]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[39]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[41]  M. Tytell,et al.  Retinal uptake of intravitreally injected Hsc/Hsp70 and its effect on susceptibility to light damage. , 2001, Molecular vision.

[42]  S. Bernstein,et al.  Heat shock cognate-70 gene expression declines during normal aging of the primate retina. , 2000, Investigative ophthalmology & visual science.

[43]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[45]  C. Reutelingsperger,et al.  Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis , 1997, Cellular and Molecular Life Sciences CMLS.

[46]  M. Tso,et al.  Antiretinal antibodies in serum of patients with age-related macular degeneration. , 1991, Ophthalmology.

[47]  H. Sakaguchi,et al.  Annexins in Bruch's membrane and drusen. , 2006, Advances in experimental medicine and biology.

[48]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[49]  P. Penfold,et al.  Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[50]  J. Provis,et al.  Autoantibodies to retinal astrocytes associated with age-related macular degeneration , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[51]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[52]  M. Killingsworth,et al.  Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.